AI in diagnostics market is rapidly growing as healthcare providers adopt advanced technologies to improve diagnostic accuracy, speed, and efficiency. Artificial intelligence helps analyze medical images, laboratory data, and patient records, assisting clinicians in detecting diseases such as cancer, neurological disorders, cardiovascular conditions, and infectious diseases at an earlier stage.

According to Fortune Business Insights, the AI in diagnostics market was valued at USD 5.15 billion in 2024. The market is projected to grow from USD 7.03 billion in 2025 to USD 96.52 billion by 2032, exhibiting a CAGR of 45.4% during the forecast period. In 2024, North America dominated the AI in diagnostics market with a market share of 51.46%.

🎯 Top Companies Shaping the Market

• Amazon.com, Inc. (U.S.)
• Microsoft Corporation (U.S.)
• NVIDIA Corporation (U.S.)
• Google (U.S.)
• Siemens Healthcare Private Limited (Germany)
• Aidoc (Israel)
• PathAI, Inc. (U.S.)
• Digital Diagnostics Inc. (U.S.)
• Tempus AI (U.S.)
• Qure.ai (U.S.)

Key Industry Development

In December 2024, Siemens Healthineers AG and DeepHealth, Inc. announced a strategic partnership. Their collaboration integrates AI-powered health informatics into ultrasound systems—enhancing real-time interpretation and workflow efficiency in imaging.

Market Drivers & Restraints

The main growth drivers include:

• Chronic disease prevalence: Diseases like cancer, cardiovascular disorders, and neurological conditions are on the rise, favoring early‑stage detection via AI-enabled tools for better clinical outcomes.
• Healthcare workforce shortage: A 2021 UK report highlighted a 33–40% shortfall in radiologists—making AI crucial to fill diagnostic gaps.